Abstract:
The present invention relates to endoglucanases having xanthan degrading activity and polynucleotides encoding the endoglucanases. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the endoglucanases.
Abstract:
Disclosed herein are methods of chemical conjugation comprising contacting a lysosomal enzyme with a first crosslinking agent to introduce aldehyde groups; contacting a lysosomal targeting peptide with a second crosslinking agent to introduce a hydrazide group at the N-terminal residue; contacting the lysosomal enzyme with aldehyde groups of step a. with the lysosomal targeting peptide with a hydrazide group at the N-terminal residue of step b; and forming a lysosomal enzyme-lysosomal targeting peptide conjugate.
Abstract:
Compositions comprising unprocessed cell pellets of a cellulosome-producing microorganism grown on cellulosic biomass are provided. Further provided are methods for producing the compositions and uses thereof in hydrolysis of cellulosic substrates. In particular, the compositions advantageously contain extracellular beta-glucosidase, either expressed on the cells themselves or extrinsically added to the cell pellets.
Abstract:
The present disclosure relates to variant CBH II polypeptides that have improved specific activity, and compositions, e.g., cellulase compositions, comprising variant CBH II polypeptides. The variant CBH II polypeptides and related compositions can be used in variety of agricultural and industrial applications. The present disclosure further relates to nucleic acids encoding variant CBH II polypeptides and host cells that recombinantly express the variant CBH II polypeptides.
Abstract:
The present invention relates to isolated Rasamsonia promoter DNA sequences, to DNA constructs, vectors, and host cells comprising these promoters in operative association with coding sequences. The present invention also relates to methods for expressing a gene and/or producing a biological compound using the new promoters isolated. The present invention also relates to methods for altering the transcription level and/or regulation of an endogenous gene using the new promoter of the invention.
Abstract:
A method and system for producing lactic acid from biomass materials uses a mixed bacteria culture of at least one homofermentative lactic acid bacteria and at least one heterofermentative lactic acid bacteria in an integrated production system to increase the productivity and yield of lactic acid.
Abstract:
The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Abstract:
The present invention relates to a process for degrading biomass or pretreated biomass wherein an enzyme is used comprising a polypeptide having a. a polypeptide sequence as set forth in any one of SEQ ID Nos:3, 6, 9, 12, 15, 8, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 59, 61, 63, 65, 67, 69 and 71; b. a polypeptide that is at least 60%, preferably at least 70%, more preferably at least 80%, even more preferably at least 90%, 95%, 96%, 97%, 98% or 99% homologous to the any one of SEQ ID Nos:3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 59, 61, 63, 65, 67, 69 and 71; c.a polypeptide sequence encoded by nucleic acids sequence as set forth in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 56, 58,60, 62, 64, 66, 68 and 70, or nucleic acids that are at least 60%, preferably at least 70%, more preferably at least 80%, even more preferably at least 90%, 95%, 96%, 97%, 98% or 99% homologous to any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 56, 58, 60, 62, 64, 66, 68 and 70; d.a polypeptide sequence encoded by a nucleic acids sequence hybridizing under stringent conditions to the polynucleotide as set forth in any one of 2 SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 55, 56, 58, 60, 62, 64, 66, 68 and 70; or e.a polypeptide sequence encoded by a nucleic acids sequence hybridizing under stringent conditions to the reverse complement of a polynucleotide as set forth in any one of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23, 25, 26, 28, 29, 31, 32, 34, 35, 37, 38, 40, 41, 43, 44, 46, 47, 49, 50, 52, 53, 56, 58, 60, 62, 64, 66, 68 and70.
Abstract translation:本发明涉及降解生物质或预处理的生物质的方法,其中使用的酶包括具有a。 如SEQ ID No:3,6,9,12,158,21,24,27,30,33,36,39,42,45,48,51,54,54,45,45,48,45,45,45,45,45,45,45,45,45,45,45,45,45,55,55,52,52,58,54,54,54,54,54,54,54,54,54,54,54,54 57,59,61,63,65,67,69和71; 湾 与下列任何一种的至少60%,优选至少70%,更优选至少80%,甚至更优选至少90%,95%,96%,97%,98%或99%同源的多肽 SEQ ID No:3,6,9。12,15, 67,69和71; 由SEQ ID NO:1,2,4,5,7,8,10,11,13,14,16,17,19,20,22,23中任一个所示的核酸序列编码的多肽序列 ,25,26,28,29,31,32,34,35,37,38,40,41,43,44,46,47,49,50,52,53,56,58,60,62,64 ,66,68和70,或至少60%,优选至少70%,更优选至少80%,甚至更优选至少90%,95%,96%,97%,98%或 与SEQ ID NO:1,2,4,5,7,8,10,11,13,14,16,17,19,20,22,23,25,26,28,29中的任一个同源的99% ,31,32,34,35,37,38,40,41,43,44,46,47,49,50,52,53,56,58,60,62,64,66,68和70; da多肽序列,其由在严格条件下与如SEQ ID NO:2,4,5,7,8,10,11,13,14,16, 17,19,20,22,23,25,26,28,29,31,32,34,35,37,38,40,41,43,44,46,47,49,50,52,53, 55,56,58,60,62,64,66,68及70条; 或由在严格条件下杂交的核酸序列编码的ea多肽序列与如SEQ ID NO:1,2,4,5,7,8,10,11,13, 14,16,17,19,20,22,23,25,26,28,29,31,32,34,35,37,38,40,41,43,44,46,47,49,50, 52,53,56,58,60,62,64,66,68和70。